Unique patterns of the selection and change in circulating tumor cell (CTC) phenotypes and genotypes by drug class in metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Scher, Howard I.
Schonhoft, Joseph
Graf, Ryon P.
Dago, Angel E.
Lee, Jerry
Sutton, Ramsay
Schreiber, Nicole A.
Hullings, Melanie
Jendrisak, Adam
Wang, Yipeng
Landers, Mark Andrew
Dittamore, Ryan
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Epic Sci Inc, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.5053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5053
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Circulating tumor cell (CTC) rise and outcome in patients with metastatic castration-resistant prostate cancer (mCRPC) with low baseline CTC counts.
    Lorente, David
    Olmos, David
    Mateo, Joaquin
    Zafeiriou, Zafeiris
    Rescigno, Pasquale
    Bianchini, Diletta
    Mehra, Niven
    Molina, Arturo
    Kheoh, Thian
    Baeten, Kurt
    Mccormack, Robert Thomas
    Terstappen, Leon W. M. M.
    Scher, Howard I.
    De Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Evaluation of clinical phenotype, survival, and circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC).
    Bitting, Rhonda Lynn
    Healy, Patrick
    Halabi, Susan
    George, Daniel J.
    Ko, Jung Hyun
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC)
    Gupta, Santosh
    Halabi, Susan
    Kemeny, Gabor
    Anand, Monika
    Nanus, David M.
    Giannakakou, Paraskevi
    George, Daniel J.
    Gregory, Simon
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [4] CK- and small nuclear size circulating tumor cell (CTCs) phenotypes in metastatic castration-resistant prostate cancer (mCRPC)
    Ferraldeschi, Roberta
    McDaniel, Andrew
    Krupa, Rachel
    Louw, Jessica
    Tucker, Eric
    Bales, Natalee
    Marrinucci, Dena
    Riisnaes, Ruth
    Mateo, Joaquin
    Dittamore, Ryan
    De Bono, Johann Sebastian
    Tomlins, Scott A.
    Attard, Gerhardt
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [5] Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer
    Bitting, Rhonda L.
    Healy, Patrick
    Halabi, Susan
    George, Daniel J.
    Goodin, Michael
    Armstrong, Andrew J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (03) : 110.e1 - 110.e9
  • [6] Chromosomal instability (CIN) in circulating tumor cells (CTC) predicts for taxane sensitivity in metastatic castration-resistant prostate cancer (mCRPC).
    Keegan, Niamh M.
    Arfe, Andrea
    Barnett, Ethan
    Cohn, Erica Dayan
    Zhao, Jimmy
    Carbone, Emily
    Zanone, Michelle
    Anderson, Amanda
    Wenstrup, Rick
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in progressive metastatic castration resistant prostate cancer (mCRPC).
    Dittamore, Ryan
    Louw, Jessica
    Krupa, Rachel
    Anand, Aseem
    Danila, Daniel Costin
    Arslan, Zaina
    Bales, Natalee
    Marrinucci, Dena
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [8] Evaluation of a composite biomarker panel including circulating tumor cell (CTC) enumeration as a surrogate for survival in metastatic castration-resistant prostate cancer (mCRPC)
    Scher, H. I.
    Heller, G.
    Molina, A.
    Attard, G.
    McCormack, R.
    Riisnaes, R.
    Kheoh, T.
    Fleisher, M.
    Buyse, M.
    De Bono, J. S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S679 - S679
  • [9] Circulating tumor cell (CTC) enumeration in patients with metastatic neuroendocrine prostate cancer (NEPC) and castration-resistant prostate cancer (CRPC)
    Kaur, Gurveen
    Singh, Beerinder
    Beltran, Himisha
    Akhtar, Naveed Hassan
    Nanus, David M.
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [10] Impact of circulating tumor cell (CTC) nucleus size on outcomes with abiraterone acetate (AA) therapy in men with metastatic castration-resistant prostate cancer (mCRPC)
    Gill, David Michael
    Agarwal, Neeraj
    Hahn, Andrew W.
    Johnson, Eric
    Poole, Austin
    Carroll, Emma
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345